F/m Emerald Life Sciences Innovation ETF
LFSC
3 hedge funds and large institutions have $60.6M invested in F/m Emerald Life Sciences Innovation ETF in 2025 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.
21% more capital invested
Capital invested by funds: $50.2M → $60.6M (+$10.4M)
0% more funds holding
Funds holding: 3 → 3 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
4.68% less ownership
Funds ownership: 91.13% → 86.45% (-4.7%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
+$2.67K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$21K |
| 2 |
HAIM
Hunter Associates Investment Management
Pittsburgh,
Pennsylvania
|
-$3.85K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
EMFAT
1
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
| $59.4M | – | – | – |
|
|
HAIM
2
Hunter Associates Investment Management
Pittsburgh,
Pennsylvania
| $1.21M | -$3.85K | -144 | -0.4% |
|
|
ASN
3
Advisory Services Network
Atlanta,
Georgia
| $2.97K | +$2.67K | +100 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| – | -$21K | -853 | Closed |
|
LFSC Hedge Fund Activity: Q3 2025 in Review
3 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in F/m Emerald Life Sciences Innovation ETF (LFSC) for Q3 2025, worth a combined $60.6M — up 21% from $50.2M a quarter earlier.
Fund positioning in LFSC was balanced in Q3 2025: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 1 trimmed.
The largest buyer was Advisory Services Network, opening a new position worth an estimated $2.67K. The largest seller was UBS Group, exiting entirely with an estimated $21K sold.
- 3 institutional investors held F/m Emerald Life Sciences Innovation ETF (LFSC) as of Q3 2025, unchanged from Q2 2025.
- Funds reported $60.6M of F/m Emerald Life Sciences Innovation ETF stock for Q3 2025, up 21% quarter-over-quarter.
- 1 fund opened new F/m Emerald Life Sciences Innovation ETF positions in Q3 2025 and 1 closed out, a net change of 0 holders.
- The largest F/m Emerald Life Sciences Innovation ETF buyer in Q3 2025 was Advisory Services Network, an estimated $2.67K added.
- The largest F/m Emerald Life Sciences Innovation ETF seller in Q3 2025 was UBS Group, an estimated $21K sold.
Based on aggregated 13F filings for Q3 2025.